Development of blood-based biomarker tests for early detection of colorectal neoplasia: Influence of blood collection timing and handling procedures

被引:9
|
作者
Pedersen, Niels Lech [1 ]
Petersen, Mathias Mertz [1 ]
Ladd, Jon J. [2 ]
Lampe, Paul D. [2 ]
Bresalier, Robert S. [3 ]
Davis, Gerard J. [4 ]
Demuth, Christina [5 ]
Jensen, Sarah O. [5 ]
Andersen, Claus L. [5 ]
Ferm, Linnea [1 ]
Christensen, Ib J. [1 ]
Nielsen, Hans J. [1 ,6 ]
机构
[1] Hvidovre Univ Hosp, Dept Surg Gastroenterol, Hvidovre, Denmark
[2] Fred Hutchinson Canc Res Ctr, Translat Res Program, 1124 Columbia St, Seattle, WA 98104 USA
[3] MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX USA
[4] Abbott Labs Inc, Canc Core R&D, Abbott Pk, IL USA
[5] Aarhus Univ Hosp, Dept Mol Med, Skejby, Denmark
[6] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark
基金
美国国家卫生研究院;
关键词
Colorectal cancer; Biomarkers; Preanalytical variation; Bowel preparation; Centrifugation; AFP; CA19-9; CEA; hs-CRP; CyFra21-1; Ferritin; Galectin-3; TIMP-1; BAG4; IL6ST; vWF; CD44; EGFR; ligand; cfDNA; BIOLOGICAL VARIATION; BIOACTIVE SUBSTANCES; BOWEL PREPARATION; TUMOR-MARKERS; CANCER; RECOMMENDATIONS; COLONOSCOPY; TRIAGE; SERUM; PANEL;
D O I
10.1016/j.cca.2020.03.035
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Introduction: Blood-based, cancer-associated biomarkers are susceptible to a variety of well-known preanalytical factors. The influence of bowel preparation before a diagnostic colonoscopy on biomarker levels is, however, poorly investigated. The present study assessed the influence of bowel preparation on colorectal cancer-associated biomarkers. In addition, the effect of single versus double centrifugation of plasma biomarkers was assessed. Methods: Blood samples were collected pre- and post-bowel preparation from 125 subjects scheduled for first time diagnostic colonoscopy due to symptoms attributable to CRC. The samples were separated into serum and EDTA plasma, and analyzed by four independent collaborators for: 1) the proteins AFP, CA19-9, CEA, hs-CRP, CyFra21-1, Ferritin, Galectin-3 and TIMP-1, 2) the proteins BAG4, IL6ST, vWF, CD44 and EGFR, 3) the glycoprotein Galectin-3 ligand, and 4) cell-free DNA (cfDNA). Statistical analysis of biomarker data has been performed using mixed modelling, including repeated measures. Results: The biomarkers generally showed negligible variation between pre- and post-bowel preparation except for CyFra21-1, Ferritin, BAG4 and cfDNA. CyFra21-1 levels were systematically reduced with 29% (95% CI 21-36%) by bowel preparation (p <= 0.0001). Ferritin was not significantly different between pre- and post-bowel preparation (p = 0.07), however the estimated difference (increase) was 18%. BAG4 was systematically reduced by 12% (95% CI 1-22%, p = 0.04), while cfDNA showed a significant increase of 28% (95% CI 17-39%, p < 0.0001). Double centrifugation compared to single centrifugation showed reduced vWF (ratio 0.86, p <= 0.0001) and CD44 (ratio 0.85, p = 0.016), but increased IL6ST levels (ratio 1.18, p = 0.014). Conclusions: Results of the present study demonstrated systematic, statistically significant differences between pre-bowel and post-bowel preparation levels for three independent blood-based biomarkers (BAG4, CyFra21-1, cfDNA), illustrating the importance of timing of sample collection for biomarker analyses.
引用
收藏
页码:39 / 53
页数:15
相关论文
共 50 条
  • [41] Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer
    Bhardwaj, Megha
    Terzer, Tobias
    Schrotz-King, Petra
    Brenner, Hermann
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (03) : 1 - 17
  • [42] Enhanced blood-based colorectal cancer screening with improved performance in detection of early stage disease
    Duenwald, Sven
    Greenwald, William Young
    He, Yupeng
    Xiong, Liyang
    Forouzmand, Elmira
    Gaile, Daniel
    Valouev, Anton
    Raymond, Victoria M.
    Talasaz, AmirAli
    Chudova, Darya
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 68 - 68
  • [43] Hypermethylation of SHISA3 DNA as a blood-based biomarker for colorectal cancer
    Tang, Sheng-Hui
    Hsiao, Cheng-Wen
    Chen, Wei-Liang
    Wu, Li-Wei
    Chang, Jin-Biou
    Yang, Bing Heng
    CHINESE JOURNAL OF PHYSIOLOGY, 2021, 64 (01): : 51 - 56
  • [44] Sensitivity Estimates of Blood-Based Tests for Colorectal Cancer Detection: Impact of Overrepresentation of Advanced Stage Disease
    Tao, Sha
    Hundt, Sabrina
    Haug, Ulrike
    Brenner, Hermann
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (02): : 242 - 253
  • [45] Blood-based detection of early-stage colorectal cancer using multiomics and machine learning
    Putcha, Girish
    Liu, Tzu-Yu
    Ariazi, Eric
    Bertin, Marvin
    Drake, Adam
    Dzamba, Michael
    Hogan, Greg
    Kothen-Hill, Steven
    Liao, Jeffrey
    Li, Kang
    Mahajan, Shivani
    Palaniappan, Krishnan
    Sansanwal, Poonam
    St John, John
    Ulz, Peter
    Wan, Nathan
    Warsinske, Hayley
    Weinberg, David
    Yang, Rui
    Lin, Jimmy
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [46] Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection
    El-Khoury, Victoria
    Schritz, Anna
    Kim, Sang-Yoon
    Lesur, Antoine
    Sertamo, Katriina
    Bernardin, Francois
    Petritis, Konstantinos
    Pirrotte, Patrick
    Selinsky, Cheryl
    Whiteaker, Jeffrey R.
    Zhang, Haizhen
    Kennedy, Jacob J.
    Lin, Chenwei
    Lee, Lik Wee
    Yan, Ping
    Tran, Nhan L.
    Inge, Landon J.
    Chalabi, Khaled
    Decker, Georges
    Bjerkvig, Rolf
    Paulovich, Amanda G.
    Berchem, Guy
    Kim, Yeoun Jin
    CANCERS, 2020, 12 (06) : 1 - 15
  • [47] Predicting Response to PRRT: Development and Validation of a Blood-Based Predictive Biomarker
    Bodei, L.
    Kidd, M.
    Van der Zwan, W.
    Singh, A.
    Severi, S.
    Drozdov, I
    Cwikla, J.
    Baum, R. P.
    Paganelli, G.
    Kwekkeboom, D.
    Krenning, E.
    Modlin, I
    NEUROENDOCRINOLOGY, 2018, 106 : 241 - 241
  • [48] Blood-based extracellular vesicle biomarker test for detection of early-stage pancreatic cancer.
    Hinestrosa, Juan P.
    Lewis, Jean M.
    Balcer, Heath I.
    Kurzrock, Razelle
    Lippman, Scott
    Krishnan, Rajaram
    CANCER RESEARCH, 2022, 82 (12)
  • [49] ADAM17-A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer
    Rogmans, Christoph
    Kuhlmann, Jan Dominik
    Hugendieck, Gerrit
    Link, Theresa
    Arnold, Norbert
    Weimer, Joerg Paul
    Floerkemeier, Inken
    Rambow, Anna-Christina
    Lieb, Wolfgang
    Maass, Nicolai
    Bauerschlag, Dirk O.
    Hedemann, Nina
    CANCERS, 2021, 13 (21)
  • [50] Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer
    Ganepola AP Ganepola
    Joel Nizin
    John R Rutledge
    David H Chang
    World Journal of Gastrointestinal Oncology, 2014, (04) : 83 - 97